Potency Assays for Modern Biologics: Expert Insights and Future Trends, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how potency assay strategies play an instrumental role across all development stages of biologics by providing biologically meaningful measures of a product's biological function and quality. The featured speakers will discuss phase-appropriate assay design, regulatory expectations and approaches for complex therapeutic modalities. Attendees will also explore how platform technologies, reporter cell systems, automation and improved product characterization are shaping future potency testing strategies.

TORONTO, Oct. 28, 2026 /PRNewswire/ -- As the biologics landscape becomes increasingly complex and therapeutic modalities grow more sophisticated, potency assay strategies are evolving from regulatory requirements into powerful tools that provide biologically meaningful measures of product function, quality and mechanism of action.

Join this expert-led webinar exploring how developers can design potency testing strategies that generate biologically relevant insights into therapeutic candidates while meeting regulatory expectations.

Potency testing sits at the intersection of product characterization, quality control and regulatory compliance, making it one of the most critical and challenging aspects of biologics development. Potency is considered a critical quality attribute (CQA) that links a therapeutic product's mechanism of action (MoA) to its clinical effect and supports biological understanding throughout the development continuum.

In this webinar, industry experts will explore how to develop successful potency strategies for biologics and increasingly complex therapeutic modalities. The panelists will discuss key decisions and pitfalls, lessons learned, best practices and practical strategies for developing potency assays that are scientifically relevant, fit-for-purpose and phase-appropriate.

As novel therapeutic modalities continue to emerge, developers require function-reflective assays that provide reliable and quantitative measures of biological activity. The speakers will also examine how innovations such as platform technologies, engineered reporter cell systems, assay-ready formats, automation and improved product characterization are shaping the next generation of potency strategies.

Register for this webinar to learn how robust potency testing can support meaningful measures of biological activity, product quality and regulatory readiness across biologics development.

Join Silvia Mattick, People & Science Lead, Senior Scientist, Roche; Paulo Roky Bamert, Associate Director, Analytical Development Bioanalytics, Novartis Pharma AG; Agnieszka Lewandowska, Associate Director, Analytical Development CMC, Immunocore; and Therese Segerstein (Moderator), Portfolio Director, Svar Life Science, for the live webinar on Wednesday, November 11, 2026, at 9:30am EST (3:30pm CET / EU-Central).

For more information, or to register for this event, visit Potency Assays for Modern Biologics: Expert Insights and Future Trends.

ABOUT SVAR LIFE SCIENCE

Svar Life Science is a life science company with proud Scandinavian roots and values, and a global perspective. We offer a unique combination of scientific expertise, high-quality assay products, contract research services, and proprietary technology platforms that together provide a flexible, effective, and seamless experience for customers through different development needs in a way that no other single business can.

Our Potency capabilities help biopharma companies design, develop, validate, and optimize function-reflective, biologically relevant assays that generate robust, reliable data to support critical development and regulatory decisions. Backed by strong expertise in immunology, immunogenicity, complement biology, and cell-based assay custom development, we help customers navigate evolving expectations for potency testing as therapies become increasingly sophisticated.

At Svar, we help you tackle your development problems, so that you can safely and efficiently progress your candidates through the drug development phases and to the patient.

To learn more about Svar Life Science, visit https://www.svarlifescience.com/

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks